Kivalo I, Saarikoski S
Br J Anaesth. 1977 Oct;49(10):1017-21. doi: 10.1093/bja/49.10.1017.
Measurements of placental transmission of atropine were performed during Caesarean section. Twenty-five patients received 3H-atropine 0.5 microgram . kg-1 i.v. 1-30 min before delivery. Maternal venous blood was sampled before the induction of anaesthesia and at the moment of delivery, together with umbilical arterial and venous blood. Total hydrogen-3 activity was determined by liquid scintillation counting. The stability of 3H-atropine was confirmed by paper chromatography. The concentrations in the umbilical vein 1 and 5 min after injection were respectively 12% and 93% of the corresponding maternal value. Those in the umbilical artery were approximately 50% of those in the umbilical vein during the same period.
剖宫产术中对阿托品的胎盘转运情况进行了测定。25例患者在分娩前1 - 30分钟静脉注射3H-阿托品0.5微克/千克。在麻醉诱导前及分娩时采集母体外周静脉血,同时采集脐动脉血和脐静脉血。通过液体闪烁计数法测定总氚活性。通过纸色谱法确认了3H-阿托品的稳定性。注射后1分钟和5分钟时脐静脉中的浓度分别为母体相应浓度的12%和93%。同期脐动脉中的浓度约为脐静脉浓度的50%。